Yeah fun for trends when news is on but this is driven largely by news events still and will be until a steady stream of revenues is flowing...
it’s a pre-revenue biotech - with the license deals in place we will trigger payments through clinical trial milestones... new lic deals etc.
and with 7 trials underway we just don’t know when the news that fundamentally rewrites price will land - the company and investors will have plans around this but it will drop when it does.![]()
- Forums
- ASX - By Stock
- KZA
- KZA Chart
KZA Chart, page-227
-
- There are more pages in this discussion • 333 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add KZA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online